Trulieve Cannabis (TRUL) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
23 Nov, 2025Executive summary
Q2 2025 revenue was $302 million, stable year-over-year, with 94% from retail sales and a strong gross margin of 61%; adjusted EBITDA reached $111 million (37% margin), reflecting disciplined expense control and operational efficiency.
Net loss attributable to common shareholders was $14 million; adjusted net loss was $8 million, excluding non-recurring items; loss per share was $0.07, or $0.04 adjusted.
Retail traffic and units sold increased 8% and 9% year-over-year, offset by pricing compression and loyalty point redemption; market share grew in Arizona and Florida, and branded product sales rose in Pennsylvania.
Wholesale revenue grew 27% year-over-year, with expanded relationships in Maryland, Pennsylvania, and Ohio, and continued focus on branded products, distribution, and customer experience.
Cash at quarter end was $401 million, with free cash flow of $75 million in Q2 and $108 million in the first half of 2025.
Financial highlights
Gross profit was $183 million (61% margin), up 1% year-over-year; SG&A expenses were $101 million (33% of revenue), comparable to last year.
Retail revenue was $284 million, down 2% year-over-year but up 1% sequentially; wholesale revenue rose 27% year-over-year and 11% sequentially.
Operating expenses were $130 million, flat year-over-year, representing 43% of revenue.
Cash flow from operations in Q2 was $86 million; free cash flow was $75 million.
Sold over 12.5 million branded products in Q2, a 9% increase year-over-year.
Outlook and guidance
Q3 2025 revenue expected to decline mid-single digits sequentially due to seasonality; full-year gross margin expected to remain around 60%.
Full-year cash flow from operations projected at least $250 million, with capital expenditures up to $40 million.
Guidance may be revised later in the year depending on macroeconomic conditions and reform progress.
Management emphasized progress on the 2025 plan, focusing on customers, distribution, branded products, and reform.
Company is positioned for accelerated growth and expansion through its hub strategy.
Latest events from Trulieve Cannabis
- 2025 revenue hit $1.2B with 60% gross margin, record EBITDA, and strong cash flow.TRUL
Q4 202526 Feb 2026 - Q2 revenue hit $303M, margins expanded, and tax uncertainties remain a key risk.TRUL
Q2 20242 Feb 2026 - Strong Q2 retail growth, robust loyalty adoption, and Florida poised for rapid adult-use expansion.TRUL
Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase2 Feb 2026 - Q3 revenue up 3% to $284M, 61% gross margin, $96M adjusted EBITDA, net loss $60M.TRUL
Q3 202416 Jan 2026 - Retail expansion, operational efficiency, and customer focus drive growth amid evolving regulations.TRUL
27th Annual Needham Growth Conference10 Jan 2026 - 2024 revenue rose 5% to $1.2B, with record cash flow and ongoing IRS 280E tax challenge.TRUL
Q4 202423 Dec 2025 - Federal rescheduling and Florida reform efforts drive optimism, as consumer and product trends evolve.TRUL
Canaccord Genuity’s 45th Annual Growth Conference23 Nov 2025 - Q1 2025 revenue reached $298M with 62% margin, strong cash flow, and continued retail growth.TRUL
Q1 202521 Nov 2025 - Q3 2025 delivered $288M revenue, 59% margin, $103M EBITDA, and strong cash flow.TRUL
Q3 202513 Nov 2025